Gene set enrichment analysis identified gene pathways involved in cell replication and metabolism as active in SMAD2(+) glioma cells, while SMAD1(+) glioma cells showed upregulation of gene associated with cellular immune response, developmental processes, and exocytosis, suggestive of a drug-resistant population (Fig. 1D). This evidence concerns the gene SMAD2 and central nervous system cancer.